Does CANAKINUMAB Cause Eosinophilia? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Eosinophilia have been filed in association with CANAKINUMAB (Ilaris). This represents 0.2% of all adverse event reports for CANAKINUMAB.
21
Reports of Eosinophilia with CANAKINUMAB
0.2%
of all CANAKINUMAB reports
2
Deaths
10
Hospitalizations
How Dangerous Is Eosinophilia From CANAKINUMAB?
Of the 21 reports, 2 (9.5%) resulted in death, 10 (47.6%) required hospitalization, and 2 (9.5%) were considered life-threatening.
Is Eosinophilia Listed in the Official Label?
Yes, Eosinophilia is listed as a known adverse reaction in the official FDA drug label for CANAKINUMAB.
What Other Side Effects Does CANAKINUMAB Cause?
Pyrexia (1,327)
Inappropriate schedule of drug administration (1,238)
Drug ineffective (1,078)
Inappropriate schedule of product administration (944)
Pain (858)
Condition aggravated (771)
Malaise (684)
Off label use (557)
Arthralgia (555)
Rash (505)
What Other Drugs Cause Eosinophilia?
ALBUTEROL (1,054)
PREDNISONE (815)
CLOZAPINE (806)
MONTELUKAST (741)
PANTOPRAZOLE (709)
VANCOMYCIN (695)
MEPOLIZUMAB (606)
ALLOPURINOL (554)
BUDESONIDE\FORMOTEROL (553)
PIPERACILLIN\TAZOBACTAM (530)
Which CANAKINUMAB Alternatives Have Lower Eosinophilia Risk?
CANAKINUMAB vs CANDESARTAN
CANAKINUMAB vs CANDESARTAN CILEXETIL
CANAKINUMAB vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE
CANAKINUMAB vs CANGRELOR
CANAKINUMAB vs CANIS LUPUS FAMILIARIS SKIN